Hostname: page-component-7479d7b7d-qs9v7 Total loading time: 0 Render date: 2024-07-13T05:50:41.943Z Has data issue: false hasContentIssue false
  • English
  • Français

Recent Advances in the Understanding and Treatment of Anxiety Disorders

Published online by Cambridge University Press:  07 November 2014

Dan J. Stein
Dan J. Stein*
Affiliation:
Dr. Stein is professor and chair of the Department of Psychiatry at the, University of Cape Town in South Africa, and is on the faculty at Mount Sinai School of Medicine in New York City
*
Dan J. Stein, MD, PhD, UCT Department of Psychiatry, Groote Schuur Hospital J-Block, Observatory 7925, Cape Town, South Africa; Tel: +27-21-404-2164; Fax: +27-21-933-5790; E-mail: dan.stein@curie.uct.ac.za
Get access Rights & Permissions [Opens in a new window]

Extract

Anxiety disorders are the most prevalent of the psychiatric disorders, account for a significant proportion of mental illness costs, and include some of the most disabling medical disorders. Anxiety disorders, which currently include the obsessive-compulsive disorders, continue to be poorly diagnosed and undertreated across a broad range of countries. It is possible that the universal experience of anxiety as an adaptive emotion makes it more difficult for patients and clinicians to conceptualize symptoms in terms of psychopathology.

Nonetheless, there have been significant advances in our understanding of anxiety and obsessive-compulsive disorders, and in our ability to manage these conditions successfully. Research on anxiety and obsessive-compulsive disorders exemplifies the goals of translational investigation; preclinical work has not only allowed an exploration of known clinical phenomena, but has also led directly to novel clinical interventions. Investigators around the globe are continuing to contribute to research on anxiety and obsessive-compulsive disorders.

Type
Research Article
Information
CNS Spectrums , Volume 11 , Issue S12 , 2006 , pp. 4
Copyright
Copyright © Cambridge University Press 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Kessler, RC, Berglund, P, Demler, O, et al.Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62: 593–602.CrossRefGoogle ScholarPubMed
2.Dupont, RL, Rice, DP, Miller, LS, et al.Economic costs of anxiety disorders. Anxiety. 1996;2;167–172.3.0.CO;2-L>CrossRefGoogle ScholarPubMed
3.Murray, CJL, Lopez, AD. Global Burden of Disease: A Comprehensive Assessment of Mortality and Morbidity from Diseases, Injuries and Risk Factors in 1990 and Projected to 2020. Vol I. Geneva, Switzerland: Harvard School of Public Health; 1996.Google Scholar
4.Kessler, RC, Demler, O, Frank, RG, et al.Prevalence and treatment of mental disorders, 1990 to 2003. New Engl J Med. 2005;352:2515–2523.CrossRefGoogle ScholarPubMed
5.Stein, MB, Sherbourne, CD, Craske, MG, et al.Quality of care for primary care patients with anxiety disorders. Am J Psychiatry. 2004;161;2230–2237.CrossRefGoogle ScholarPubMed
6.Stein, DJ, Hollander, E, Rowland, C, Serebro, P, Roberts, M. Quality of life and pharmacoeconomic aspects of obsessive-compulsive disorder: A South African survey. S Afr Med J. 1996;86:1579–1585.Google ScholarPubMed
7.Stein, DJ, Hollander, E. Textbook of Anxiety Disorders. Washington, DC: American Psychiatric Press; 2002.Google Scholar
8.Ballenger, JC. Treatment of anxiety disorders to remission. J Clin Psychiatry. 2001;62(suppl 12):5–9.Google ScholarPubMed
9.Le Doux, J. Fear and the brain: Where have we been, and where are we going? Biol Psychiatry. 1998;44:1229–1238.CrossRefGoogle ScholarPubMed
10.Ressler, KJ, Rothbaum, BO, Tannenbaum, L, et al.Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear. Arch Gen Psychiatry. 2004;61:1136–1144.CrossRefGoogle ScholarPubMed
11.Committee on Nervous System Disorders in Developing Countries, Board on Global Health. Neurological, Psychiatric and Developmental Disorders - Meeting the Challenge in the Developing World. Washington, DC: Institute of Medicine, Academy Press; 2001.Google Scholar
12.Bergen, DC, Silberberg, D. Nervous system disorders: a global epidemic. Arch Neurol. 2002;59:1194–1196.CrossRefGoogle ScholarPubMed